Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Caicun Zhou, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng Chih Lin, Margarita Majem, Oliver Gautschi, Jhanelle Elaine Gray, Michael J. Boyer, Juliann Chmielecki, Ryan Hartmaier, Krishna Bulusu, J Carl Barrett, Rachel Hodge, Matilde Saggese, Astrid McKeown, Suresh S. Ramalingam
Institutions: Tongji University, Shanghai Pulmonary Hospital, Osaka International Cancer Institute, Jilin Province Tumor Hospital, Kyushu University, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Hospital de Sant Pau, University of Bern, Luzerner Kantonsspital, Moffitt Cancer Center, Chris O’Brien Lifehouse, AstraZeneca (United States), AstraZeneca (United Kingdom), Winship Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947511099